Skip to Main Content

Author Details

Eyad Abu-Isa
Ascension Providence Hospital
2005
29
12
PMIDPaper TitleJournal TitlePublished Year
37797748Factors Associated With Cardiac Radiation Dose Reduction After Hypofractionated Radiation Therapy for Localized, Left-Sided Breast Cancer in a Large Statewide Quality Consortium.Int J Radiat Oncol Biol Phys2024
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
34718094Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.Int J Radiat Oncol Biol Phys2022
36397912Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.Cureus2022
35916737Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients.J Natl Cancer Inst2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34634437Comparative Effectiveness Analysis of 3D-Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy (IMRT) in a Prospective Multicenter Cohort of Patients With Breast Cancer.Int J Radiat Oncol Biol Phys2022
33432297Risk of in-hospital death associated with Covid-19 lung consolidations on chest computed tomography - A novel translational approach using a radiation oncology contour software.Eur J Radiol Open2021
33557650Clinical effects of morning and afternoon radiotherapy on high-grade gliomas.Chronobiol Int2021
33631205Efficacy and Incontinence Rates After Urethroplasty for Radiation-induced Urethral Stenosis: A Systematic Review and Meta-analysis.Urology2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
34112334AUTHOR REPLY.Urology2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
32376738Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer.Int J Gynecol Cancer2020
32376311The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.Int J Radiat Oncol Biol Phys2020
30724780Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization.Am J Clin Oncol2019
29509865Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.JAMA2018
29976500Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.Int J Radiat Oncol Biol Phys2018
26853347Depigmentation Within the Radiation Field in Patients With Vitiligo.Int J Radiat Oncol Biol Phys2016
25683183High-grade undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: emerging entities of soft tissue tumors with unique histopathologic features--a case report and literature review.Am J Case Rep2015
25911994Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5.Brachytherapy2015
22893254The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.Cancer2013
22681643Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy.Radiat Oncol2012
18607504Radiosensitization by gemcitabine fixed-dose-rate infusion versus bolus injection in a pancreatic cancer model.Transl Oncol2008
18506734Toxicity of radiotherapy in patients with collagen vascular disease.Cancer2008
17011452External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.Int J Radiat Oncol Biol Phys2006
15994918Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.Cancer Res2005
  • 1 - 29 of 29

Recommended Authors

David Geffen School of Medicine, University of California los angeles
Career Start Year 2018
Number of shared co-authors 32
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 3
Stanford University
Career Start Year 2014
Number of shared co-authors 25
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 16
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 4
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 25
Stanford University
Career Start Year 2012
Number of shared co-authors 8
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 1
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 13
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 4
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 19
University of Liege, Centre Hospitalier Universitaire de Liege
Career Start Year 2005
Number of shared co-authors 0
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 14
Cedars Sinai Medical Center
Career Start Year 2005
Number of shared co-authors 15
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 10
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 21
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 32
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 8
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 29
University of Chicago
Career Start Year 1997
Number of shared co-authors 25
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 30
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 46
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 10
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 36
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 15
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 9

Collaborators

University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 10
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 10
Cleveland Clinic
Co-authored papers 8
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
University of Maryland School of Medicine
Co-authored papers 8
William Beaumont School of Medicine
Co-authored papers 8
Johns Hopkins University School of Medicine
Co-authored papers 8
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Johns Hopkins University School of Medicine
Co-authored papers 8
Johns Hopkins University School of Medicine
Co-authored papers 8
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 8
Oslo University Hospital
Co-authored papers 8
University of California los angeles
Co-authored papers 8
Johns Hopkins University
Co-authored papers 8
University of California los angeles
Co-authored papers 8
Fox Chase Cancer Center
Co-authored papers 8
University of California los angeles
Co-authored papers 8
Oslo University Hospital
Co-authored papers 8
Cleveland Clinic
Co-authored papers 8
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
university of california los angeles Medical Center
Co-authored papers 7
Northwestern University
Co-authored papers 7
Vanderbilt University Medical Center
Co-authored papers 7
Johns Hopkins University School of Medicine
Co-authored papers 7
University of Michigan ann arbor
Co-authored papers 6
Cleveland Clinic
Co-authored papers 6
Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 5